# Pfizer AI Council Brainstorming Session Transcript
Date: June 10, 2026
Attendees: Dr. Angela Vance (VP Oncology Marketing), Thomas Wright (Vaccines Commercial Head), Linda Hsieh (VP Rare Disease Strategy)

---

**Angela Vance**: Thanks everyone for joining. Our core CMO mandate this quarter is to accelerate the transition of our digital marketing campaigns from generic content streams to compliant, high-conversion pipelines. Currently, digital CTRs across key oncology therapeutics are hovering below 1.5%. We need to address this bottleneck.

**Thomas Wright**: I agree. We have a massive pool of Salesforce CRM interaction logs, but we aren't using them dynamically. What if we build an **Omnichannel Digital Content Personalization Engine**? We could train a multi-armed bandit model that selects the optimal email template for general practitioners based on their previous clicks and specialty profiling.

**Angela Vance**: That sounds highly promising. If we can increase email open rates to over 30%, it could drive an estimated $410,000 in annualized commercial value for our brand marketing. We can build it on our standard AWS SageMaker stack. Let's list that as a candidate use case under the Internal Medicine and Vaccines portfolio.

**Linda Hsieh**: Another major bottleneck is ad-copy compliance. Currently, manual legal review for every new digital campaign copy takes up to 4 weeks per campaign. This is a severe time-to-market blocker.

**Angela Vance**: Yes, FDA OPDP guidelines are very strict, and we can't afford any missteps. What if we deploy an **OPDP Ad-Copy Regulatory Compliance Vetting Bot**? We could fine-tune a local language model on historical FDA warning letters and Pfizer internal steering review decisions. It can scan draft ad-copy text instantly, highlight regulatory compliance risks, and reduce copy cycles from weeks to hours.

**Thomas Wright**: That would save at least $280,000 annually in agency costs and direct reviewer overhead. The technology stack seems straightforward—we can host the model on our private corporate network to maintain total data privacy.

**Linda Hsieh**: Let's submit both concepts to the AI Council board backlog so the engineering teams can begin evaluating data readiness and technical integrations.
